AAAAAA

   
Results: 1-19 |
Results: 19
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies
Authors: Gilbert, J Baker, SD Bowling, MK Grochow, L Figg, WD Zabelina, Y Donehower, RC Carducci, MA
Citation: J. Gilbert et al., A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies, CLIN CANC R, 7(8), 2001, pp. 2292-2300
A phase I clinical and pharmacological evaluation of sodium phenylbutyrateon an 120-h infusion schedule
Authors: Carducci, MA Gilbert, J Bowling, MK Noe, D Eisenberger, MA Sinibaldi, V Zabelina, Y Chen, TL Grochow, LB Donehower, RC
Citation: Ma. Carducci et al., A phase I clinical and pharmacological evaluation of sodium phenylbutyrateon an 120-h infusion schedule, CLIN CANC R, 7(10), 2001, pp. 3047-3055
Prostate cancer - Preface
Authors: Carducci, MA Eisenberger, MA
Citation: Ma. Carducci et Ma. Eisenberger, Prostate cancer - Preface, HEMAT ONCOL, 15(3), 2001, pp. XI-XII
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors
Authors: Heath, EI O'Reilly, S Humphrey, R Sundaresan, P Donehower, RC Sartorius, S Kennedy, MJ Armstrong, DK Carducci, MA Sorensen, JM Kumor, K Kennedy, S Grochow, LB
Citation: Ei. Heath et al., Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors, CANC CHEMOT, 48(4), 2001, pp. 269-274
Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis
Authors: Pili, R Kruszewski, MP Hager, BW Lantz, J Carducci, MA
Citation: R. Pili et al., Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis, CANCER RES, 61(4), 2001, pp. 1477-1485
A phase I trial of CV706, a replication-competent, PSA selective oncolyticadenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
Authors: DeWeese, TL van der Poel, H Li, SD Mikhak, B Drew, R Goemann, M Hamper, U DeJong, R Detorie, N Rodriguez, R Haulk, T DeMarzo, AM Piantadosi, S Yu, DC Chen, Y Henderson, DR Carducci, MA Nelson, WG Simons, JW
Citation: Tl. Deweese et al., A phase I trial of CV706, a replication-competent, PSA selective oncolyticadenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy, CANCER RES, 61(20), 2001, pp. 7464-7472
Antiprogression agents for prostate cancer
Authors: Wood, HM Carducci, MA
Citation: Hm. Wood et Ma. Carducci, Antiprogression agents for prostate cancer, CONT CANC R, 2001, pp. 461-481
The role of endothelin-1 and endothelin receptor antagonists in prostate cancer
Authors: Nelson, JB Carducci, MA
Citation: Jb. Nelson et Ma. Carducci, The role of endothelin-1 and endothelin receptor antagonists in prostate cancer, BJU INT, 85, 2000, pp. 45-48
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate other histone deacetylase inhibitors
Authors: Gore, SD Carducci, MA
Citation: Sd. Gore et Ma. Carducci, Modifying histones to tame cancer: clinical development of sodium phenylbutyrate other histone deacetylase inhibitors, EXPERT OP I, 9(12), 2000, pp. 2923-2934
The Bajorin article reviewed
Authors: Carducci, MA
Citation: Ma. Carducci, The Bajorin article reviewed, ONCOLOGY-NY, 14(1), 2000, pp. 61-62
Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer
Authors: Nelson, JB Carducci, MA
Citation: Jb. Nelson et Ma. Carducci, Small bioactive peptides and cell surface peptidases in androgen-independent prostate cancer, CANCER INV, 18(1), 2000, pp. 87-96
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
Authors: Nelson, WG Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Kim, M Weber, CE Baccala, AA Goeman, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF
Citation: Wg. Nelson et al., Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies, CANC CHEMOT, 46, 2000, pp. S67-S72
Management of patients with rising prostate-specific antigen after radicalprostatectomy
Authors: Laufer, M Pound, CR Carducci, MA Eisenberger, MA
Citation: M. Laufer et al., Management of patients with rising prostate-specific antigen after radicalprostatectomy, UROLOGY, 55(3), 2000, pp. 309-315
Adjuvant chemotherapy for T3 prostate cancer: Not ready for prime time
Authors: Carducci, MA
Citation: Ma. Carducci, Adjuvant chemotherapy for T3 prostate cancer: Not ready for prime time, UROLOGY, 55(2), 2000, pp. 157-160
Complete androgen blockade for prostate cancer: What went wrong?
Authors: Laufer, M Denmeade, SR Sinibaldi, VJ Carducci, MA Eisenberger, MA
Citation: M. Laufer et al., Complete androgen blockade for prostate cancer: What went wrong?, J UROL, 164(1), 2000, pp. 3-9
Identification and characterization of circulating prostate carcinoma cells
Authors: Wang, ZP Eisenberger, MA Carducci, MA Partin, AW Scher, HI Ts'o, POP
Citation: Zp. Wang et al., Identification and characterization of circulating prostate carcinoma cells, CANCER, 88(12), 2000, pp. 2787-2795
Prostate-specific antigen and other markers of therapeutic response
Authors: Carducci, MA DeWeese, TL Nelson, JB
Citation: Ma. Carducci et al., Prostate-specific antigen and other markers of therapeutic response, UROL CLIN N, 26(2), 1999, pp. 291
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma
Authors: Carducci, MA Piantadosi, S Pound, CR Epstein, JI Simons, JW Marshall, FF Partin, AW
Citation: Ma. Carducci et al., Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma, UROLOGY, 53(1), 1999, pp. 44-49
Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
Authors: Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Lim, M Weber, CE Baccala, AA Goemann, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF Nelson, WG
Citation: Jw. Simons et al., Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer, CANCER RES, 59(20), 1999, pp. 5160-5168
Risultati: 1-19 |